PMID: 8615087Jan 1, 1995Paper

Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations

Acta Neuropathologica
A A Gabreëls-FestenF J Gabreëls

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) or hereditary motor and sensory neuropathy type Ia (HMSN type Ia) is an autosomal dominant demyelinating polyneuropathy, which may result from duplications as large as 1.5 Mb on chromosome 17p 11.2-p12 encompassing the gene for the peripheral myelin protein PMP22, or from point mutations in this gene. In general, it is not possible to distinguish, by clinical and neurophysiological criteria, the cases associated with the duplication mutation from those associated with point mutations of the PMP22 gene, although the latter tend to be more severe. In this study we demonstrated that the two genotypes exhibit different morphological characteristics. In the PMP22 duplicated cases the mean g-ratio (axon diameter versus fibre diameter) is significantly lower than normal, while in cases of PMP22 point mutations nearly all myelinated fibers have an extremely high g-ratio. In cases with point mutations, onion bulbs are abundantly present from an early age, whereas onion bulbs in the duplicated cases develop gradually in the first years of life. Increase in total transverse fascicular area is most pronounced in the point mutation cases. The differences in pathology between these two very differe...Continue Reading

References

Jun 1, 1979·Annals of Neurology·J M Killian, H W Kloepfer
Apr 1, 1992·Nature Genetics·J R LupskiP I Patel
Sep 1, 1992·Neurology·A A Gabreëls-FestenT W Janssen-van Kempen
Feb 1, 1992·Journal of the Neurological Sciences·A A Gabreëls-FestenT W Janssen-van Kempen
Dec 1, 1985·Brain : a Journal of Neurology·J M Jacobs, S Love
Nov 1, 1983·Journal of Neuropathology and Experimental Neurology·E W HenryR L Sidman
Apr 1, 1994·Trends in Genetics : TIG·P I Patel, J R Lupski
Jan 1, 1995·Human Mutation·L J ValentijnG A Nicholson
Jan 1, 1994·Neuromuscular Disorders : NMD·A A Gabreëls-FestenT W Janssen-van Kempen
Jul 8, 1993·The New England Journal of Medicine·B B RoaJ R Lupski

❮ Previous
Next ❯

Citations

Jul 22, 1998·Microscopy Research and Technique·R Naef, U Suter
Jun 30, 2000·Cell Biology International·G J Snipes, W Orfali
Feb 5, 2011·Acta Neuropathologica·Jean-Michel VallatLaurent Magy
Apr 23, 2013·Journal of Genetic Counseling·Carly E SiskindKaren M Krajewski
Dec 12, 2012·Molecular Neurobiology·Jun LiJiasong Guo
Jul 31, 1998·Trends in Neurosciences·C O Hanemann, H W Müller
Dec 31, 1997·Brain & Development·N KosukaS Chiba
Apr 1, 1997·Journal of Anatomy·A M RobertsonP K Thomas
Jan 7, 1998·Journal of Anatomy·R Martini
May 19, 2009·Brain : a Journal of Neurology·Istvan KatonaJun Li
Oct 22, 2009·Brain : a Journal of Neurology·Camiel VerhammeMarianne de Visser
Dec 1, 2003·Journal of Clinical Neuromuscular Disease·Safwan S Jaradeh
May 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J P van DijkM J Zwarts
Dec 10, 1999·Annals of the New York Academy of Sciences·P K Thomas
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J S KalkmanG Bleijenberg
Mar 22, 2014·Orphanet Journal of Rare Diseases·Barbara W van PaassenMarianne de Visser
Nov 17, 2009·Journal of the Peripheral Nervous System : JPNS·Chiara PisciottaLucio Santoro
Feb 10, 2010·Journal of Neuropathology and Experimental Neurology·Eng-Tat AngSara Sancho Oliver
Mar 12, 2011·Lancet Neurology·Marianne de Visser, Camiel Verhamme
Apr 14, 2011·Journal of Neuropathology and Experimental Neurology·Camiel VerhammeIvo N van Schaik
May 1, 2007·Journal of Psychosomatic Research·Joke S KalkmanGijs Bleijenberg
Feb 28, 2007·Neurologic Clinics·Christopher J Klein
Oct 11, 2005·Physical Medicine and Rehabilitation Clinics of North America·Gregg D Meekins, Michael D Weiss
Apr 2, 2002·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Z CaiP C Blumbergs
Oct 26, 2001·The Australian Journal of Physiotherapy·Jennifer NitzRichard Jackson
Jul 15, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F ManganelliUNKNOWN CMT-TRIAAL and CMT-TRAUK Group
Jan 1, 2007·Disability and Rehabilitation. Assistive Technology·Marleen H van der LindenBaziel G M van Engelen
Aug 4, 1999·Brain : a Journal of Neurology·S SanchoU Suter1
Aug 16, 2017·Annals of Clinical and Translational Neurology·Jun Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.